MedTrace Logo

Stem Cells Tratment for the Local Feminine Stress Urinary Incontinence Treatment (HULPURO)

NCT01804153 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2013-03-05

No results posted yet for this study

Summary

Evaluate the feasability and security of the autologous ASC for the femenine stress urinary incontinence

Conditions

Interventions

DRUG

Adipose-derived expanded stem cells

Intralesional application ASC

Sponsors & Collaborators

  • Instituto de Investigación Hospital Universitario La Paz

    lead OTHER

Principal Investigators

  • Sergio Alonso Gregorio, MD · Hospital Universitario La Paz

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-10-31
Completion
2014-04-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01804153 on ClinicalTrials.gov